Concord Wealth Partners’s 1Life Healthcare ONEM Stock Holding History

Concord Wealth Partners’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,000	Closed	-$16.7K	–	1270
2022 Q4	$16.7K	Buy	+1,000	New	+$16.9K	0.01%	558
2022 Q3	–	Sell	-1,000	Closed	-$8K	–	1263
2022 Q2	$8K	Hold	1,000	–	–	﹤0.01%	744
2022 Q1	$11K	Sell	1,000 -78	-7%	-$874	﹤0.01%	769
2021 Q4	$19K	Buy	+1,078	New	+$20.9K	﹤0.01%	665

Concord Wealth Partners's ONEM Position: Q1 2023 in Review

Concord Wealth Partners sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,000 shares — an estimated $16.7K sold.

Concord Wealth Partners first reported a position in ONEM in Q4 2021 and held it in 4 quarters. The position peaked at $19K in Q4 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

Concord Wealth Partners reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
Concord Wealth Partners sold 1,000 1Life Healthcare shares in Q1 2023, an estimated $16.7K.
Concord Wealth Partners first reported a position in 1Life Healthcare in Q4 2021 and held it in 4 quarters.
Concord Wealth Partners's 1Life Healthcare position peaked at $19K in Q4 2021.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Concord Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.